BMB-101 demonstrated a complete elimination of drop attacks in the DBA/2 mouse model - - The DBA/2 model is highly predictive ...

BMB-101 demonstrated a complete elimination of drop attacks in the DBA/2 mouse model - - The DBA/2 model is highly predictive of sudden unexpected death in epilepsy (SUDEP) - - Findings highlight ...

(RTTNews) - Bright Minds Biosciences (DRUG), Tuesday announced that BMB-101, its selective 5-HT2C Gq-biased agonist, completely abolished drop seizures in the DBA/2 mouse model of epilepsy.

Studies show that about 10 million people in India live with epilepsy. A significant portion of these cases, over 60%, begin in childhood. According to a study published in The Lancet ...

Founded in 1971, the Epilepsy Foundation Alabama provides programs and services that support people and families impacted by epilepsy. With the strength of a national organization and network of ...

In a scientific first, researchers from around 29 universities and institutions across North America have teamed up to create ...

The Epilepsy Foundation New Mexico provides programs and services that support people and families impacted by epilepsy. With the strength of a national organization and network of epilepsy experts, ...

The early months of 2025 have seen a surge of research centered on cannabidiol (CBD), with studies investigating its role in ...